Plexus price target raised to $120 from $110 at Benchmark

Benchmark raised the firm’s price target on Plexus to $120 from $110 and keeps a Buy rating on the shares. The firm has increased conviction in Plexus’s revenue trajectory, operating margin expansion, and improving cash flow following our recent visit to the company’s Wisconsin facilities, the analyst tells investors in a research note.